CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -5.9% | 11,604 | +20.8% | 0.00% | -50.0% |
| Q2 2022 | $17,000 | -74.6% | 9,604 | -62.0% | 0.00% | -66.7% |
| Q1 2022 | $67,000 | -38.0% | 25,304 | +0.6% | 0.01% | -33.3% |
| Q4 2021 | $108,000 | +145.5% | 25,154 | +269.9% | 0.01% | +80.0% |
| Q4 2020 | $44,000 | +109.5% | 6,800 | +161.5% | 0.01% | +66.7% |
| Q2 2020 | $21,000 | -46.2% | 2,600 | -51.9% | 0.00% | -25.0% |
| Q3 2019 | $39,000 | -47.3% | 5,400 | +33.5% | 0.00% | -20.0% |
| Q3 2018 | $74,000 | +34.5% | 4,046 | +65.9% | 0.01% | +25.0% |
| Q2 2018 | $55,000 | -15.4% | 2,439 | -21.7% | 0.00% | -33.3% |
| Q4 2017 | $65,000 | – | 3,115 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |